» Articles » PMID: 27833859

Associations of 25-hydroxyvitamin D with Markers of Inflammation, Insulin Resistance and Obesity in Black and White Community-dwelling Adults

Overview
Specialty Endocrinology
Date 2016 Nov 12
PMID 27833859
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Vitamin D is a fat-soluble vitamin classically known for its role in calcium absorption and bone health. Growing evidence indicates that vitamin D deficiency may be associated with inflammation, insulin resistance, and obesity. However, prior studies examining the association of vitamin D with metabolic risk factors had relatively low representation of individuals of black race, limiting their ability to characterize associations of vitamin D and parameters of metabolic health in black vs. white individuals.

Methods: We examined associations of 25-hydroxyvitamin D (25(OH)D) concentrations with markers of inflammation (interleukin [IL]-6, IL-10, high sensitivity C-reactive protein [hsCRP]), insulin sensitivity (adiponectin, resistin, HOMA-IR), and obesity (body mass index [BMI], waist circumference) in 1,042 participants from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a large national cohort of black and white adults 45 years or older.

Results: In unadjusted analyses, lower 25(OH)D concentrations were associated with higher IL-6 and hsCRP concentrations; lower adiponectin concentrations; higher HOMA-IR; and higher BMI and waist circumference (<0.05 for all). After adjustment for sociodemographic, clinical, lifestyle, and laboratory variables, lower 25(OH) D concentrations remained associated with lower adiponectin concentrations, higher IL-6 concentrations, higher HOMA-IR, and higher BMI and waist circumference ( <0.05 for all). The magnitude of these associations did not differ by race (>0.1).

Conclusions: Lower 25(OH)D concentrations are associated with disturbances in metabolic health in both blacks and whites. Whether correcting vitamin D deficiency could offer a beneficial therapy for additional disease prevention requires further study.

Citing Articles

Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy.

Stoian A, Muntean C, Baba D, Manea A, Denes L, Simon-Szabo Z Int J Mol Sci. 2024; 25(19).

PMID: 39408723 PMC: 11476795. DOI: 10.3390/ijms251910395.


Associations of serum 25-hydroxyvitamin D with hsCRP and other novel inflammatory biomarkers in children: a cross-sectional study.

Dong H, Wang F, Gao L, Xu X, Ni Y BMJ Open. 2024; 14(9):e083227.

PMID: 39242162 PMC: 11381719. DOI: 10.1136/bmjopen-2023-083227.


Pediatric primary cutaneous anaplastic large-cell lymphoma with associated hypovitaminosis D.

Tung-Hahn E, Mogilevskiy V, Black E, Morgan M, Tung R Arch Dermatol Res. 2023; 316(1):50.

PMID: 38108932 DOI: 10.1007/s00403-023-02790-4.


Vitamin D Deficiency in Obese Children Is Associated with Some Metabolic Syndrome Components, but Not with Metabolic Syndrome Itself.

Hofman-Hutna J, Hutny M, Matusik E, Olszanecka-Glinianowicz M, Matusik P Metabolites. 2023; 13(8).

PMID: 37623858 PMC: 10456245. DOI: 10.3390/metabo13080914.


Dietary inflammatory index is associated with Vitamin D in CKD patients.

Wu W, Li X, Di J, Zhou H, Niu H, Yang M Int Urol Nephrol. 2023; 56(1):335-344.

PMID: 37378851 PMC: 10776691. DOI: 10.1007/s11255-023-03679-x.


References
1.
Cushman M, Judd S, Howard V, Kissela B, Gutierrez O, Jenny N . N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Stroke. 2014; 45(6):1646-50. PMC: 4142424. DOI: 10.1161/STROKEAHA.114.004712. View

2.
Mangin M, Sinha R, Fincher K . Inflammation and vitamin D: the infection connection. Inflamm Res. 2014; 63(10):803-19. PMC: 4160567. DOI: 10.1007/s00011-014-0755-z. View

3.
de Boer I, Tinker L, Connelly S, Curb J, Howard B, Kestenbaum B . Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care. 2008; 31(4):701-7. PMC: 3046029. DOI: 10.2337/dc07-1829. View

4.
Avenell A, Cook J, MacLennan G, McPherson G . Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing. 2009; 38(5):606-9. DOI: 10.1093/ageing/afp109. View

5.
Howard V, Cushman M, Pulley L, Gomez C, Go R, Prineas R . The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005; 25(3):135-43. DOI: 10.1159/000086678. View